7 hours ago
- Nikki Schultek’s Alzheimer’s Pathobiome Initiative has documented 86 published case reports of infectious dementias where targeted antimicrobial treatment led to reversal of cognitive decline.
- Research from Schultek’s global consortium (including Dr. Robert Moir/Rudy Tanzi at Harvard/Mass General and Dr. Or Shemesh) suggests amyloid and tau may function as innate immune defenses responding to infection, rather than being purely pathological.
- Nikki Schultek is advocating for greater federal (NIH) and philanthropic investment in multidisciplinary, multi-pathogen research, along with better testing and insurance coverage to democratize access to precision infectious-disease diagnostics.
Comments